VTN and myeloid sarcoma: The transcriptional modulation of complement proteins has emerged as a defining feature of dysregulated microglia and astrocytes in MS lesions, further emphasizing their role in the inflammatory and degenerative processes associated with the disease (Absinta et al. 2021) and was confirmed in the large transcriptomic analysis by Macnair and colleagues (Table 1).